Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
90 participants
INTERVENTIONAL
2023-06-23
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To quantify axial length progression following cessation of use of specific spectacle lenses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spectacle Lens Visual Acuity Assessments Study
NCT05650190
Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)
NCT01829191
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NCT05818033
Dual Focus Soft Contact Lens Wear Cessation Study
NCT05779072
Control of Myopia Using Novel Spectacle Lens Designs
NCT03623074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Lens Group
Spectacle Lenses
Standard Spectacle Lenses
Control Lens Group
Spectacle Lenses
Standard Spectacle Lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectacle Lenses
Standard Spectacle Lenses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day);
* Willingness to participate in the trial for up to 12 months without contact lens wear;
* The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.
Exclusion Criteria
9 Years
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SightGlass Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Golden Optometric Group
Whittier, California, United States
Omega Vision Center PA
Longwood, Florida, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Advanced Eyecare PC
Raytown, Missouri, United States
Sacco Eye Group
Vestal, New York, United States
Total Eye Care
Memphis, Tennessee, United States
Vision Optique
Houston, Texas, United States
William J Bogus, OD, FAAO
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPRO-2303-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.